PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer

Clinical trial NCT07775820 · RECRUITING

Trial details

NCT number: NCT07775820
Sponsor: Nanfang Hospital, Southern Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer Rechallenge Checkpoint Inhibitor Pneumonitis

Start date: 2025-10-20
Primary completion: 2026-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.